193 related articles for article (PubMed ID: 24803739)
21. Recognition functions of pentameric C-reactive protein in cardiovascular disease.
Agrawal A; Gang TB; Rusiñol AE
Mediators Inflamm; 2014; 2014():319215. PubMed ID: 24948846
[TBL] [Abstract][Full Text] [Related]
22. Association between temporal changes in C-reactive protein levels and prognosis in patients with previous myocardial infarction - A report from the CHART-2 Study.
Oikawa T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Saga C; Ikeno Y; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
Int J Cardiol; 2019 Oct; 293():17-24. PubMed ID: 31358306
[TBL] [Abstract][Full Text] [Related]
23. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
Albert MA; Danielson E; Rifai N; Ridker PM;
JAMA; 2001 Jul; 286(1):64-70. PubMed ID: 11434828
[TBL] [Abstract][Full Text] [Related]
24. Selective apheresis of C-reactive protein: a new therapeutic option in myocardial infarction?
Sheriff A; Schindler R; Vogt B; Abdel-Aty H; Unger JK; Bock C; Gebauer F; Slagman A; Jerichow T; Mans D; Yapici G; Janelt G; Schröder M; Kunze R; Möckel M
J Clin Apher; 2015 Feb; 30(1):15-21. PubMed ID: 25044559
[TBL] [Abstract][Full Text] [Related]
25. The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction.
Hennessy T; Soh L; Bowman M; Kurup R; Schultz C; Patel S; Hillis GS
Am Heart J; 2019 Sep; 215():62-69. PubMed ID: 31284074
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.
Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Sozu T; Terashima M; Michishita I;
J Atheroscler Thromb; 2013; 20(9):717-25. PubMed ID: 23748166
[TBL] [Abstract][Full Text] [Related]
27. Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction.
Jiao Q; Ke Q; Li W; Jin M; Luo Y; Zhang L; Yang D; Zhang X
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):162-70. PubMed ID: 25399887
[TBL] [Abstract][Full Text] [Related]
28. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
[TBL] [Abstract][Full Text] [Related]
29. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.
Uehara K; Nomura M; Ozaki Y; Fujinaga H; Ikefuji H; Kimura M; Chikamori K; Nakaya Y; Ito S
Heart Vessels; 2003 May; 18(2):67-74. PubMed ID: 12756602
[TBL] [Abstract][Full Text] [Related]
30. Human C-reactive protein enhances vulnerability of immature rats to hypoxic-ischemic brain damage: a preliminary study.
Kinugasa-Taniguchi Y; Tomimatsu T; Mimura K; Kanagawa T; Shimoya K; Murata Y; Kimura T
Reprod Sci; 2010 May; 17(5):419-25. PubMed ID: 20220110
[TBL] [Abstract][Full Text] [Related]
31. Reduction of C-reactive protein is not associated with reduced cardiovascular risk and mortality in patients treated with statins. A meta-analysis of 22 randomized trials.
Savarese G; Rosano GM; Parente A; D'Amore C; Reiner MF; Camici GG; Trimarco B; Perrone-Filardi P
Int J Cardiol; 2014 Nov; 177(1):152-60. PubMed ID: 25499365
[TBL] [Abstract][Full Text] [Related]
32. Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta-Analysis.
Zhang XL; Lan RF; Zhang XW; Xu W; Wang L; Kang LN; Xu B
J Am Heart Assoc; 2019 Aug; 8(16):e012428. PubMed ID: 31411090
[TBL] [Abstract][Full Text] [Related]
33. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
Koenig W
Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
[TBL] [Abstract][Full Text] [Related]
34. Relationship between early postoperative C-reactive protein elevation and long-term postoperative major adverse cardiovascular and cerebral events in patients undergoing off-pump coronary artery bypass graft surgery: a retrospective study.
Min JJ; Nam K; Kim TK; Kim HJ; Seo JH; Hwang HY; Kim KB; Murkin JM; Hong DM; Jeon Y
Br J Anaesth; 2014 Sep; 113(3):391-401. PubMed ID: 24829443
[TBL] [Abstract][Full Text] [Related]
35. A Promising Innovative Treatment for ST-Elevation Myocardial Infarction: The Use of C-Reactive Protein Selective Apheresis: Case Report.
Boljevic D; Nikolic A; Rusovic S; Lakcevic J; Bojic M; Balint B
Blood Purif; 2020; 49(6):753-757. PubMed ID: 32114573
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of C-reactive protein and left ventricular diastolic filling pattern after a non-ST elevation myocardial infarction.
Zacharoulis A; Kotseroglou V; Lerakis S; Karavidas A; Arapi S; Zacharoulis A
Am J Med Sci; 2006 Mar; 331(3):113-8. PubMed ID: 16538070
[TBL] [Abstract][Full Text] [Related]
37. C-reactive protein, renal function, and cardiovascular outcome in patients with symptomatic peripheral artery disease and preserved left ventricular systolic function.
Vrsalović M; Vučur K; Car B; Krčmar T; Vrsalović Presečki A
Croat Med J; 2015 Aug; 56(4):351-6. PubMed ID: 26321028
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein levels and outcomes after statin therapy.
Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
[TBL] [Abstract][Full Text] [Related]
39. The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study.
Iso H; Noda H; Ikeda A; Yamagishi K; Inoue M; Iwasaki M; Tsugane S
J Atheroscler Thromb; 2012; 19(8):756-66. PubMed ID: 22785140
[TBL] [Abstract][Full Text] [Related]
40. Effects of an antisense oligonucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers.
Noveck R; Stroes ES; Flaim JD; Baker BF; Hughes S; Graham MJ; Crooke RM; Ridker PM
J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
